A phase III, randomized, controlled study to compare tivozanib with sorafenib in patients (pts) with advanced renal cell carcinoma (RCC) Meeting Abstract


Authors: Motzer, R. J.; Bhargava, P.; Esteves, B.; Al-Adhami, M.; Slichenmyer, W.; Nosov, D.; Eisen, T.; Sternberg, C. N.; Hutson, T. E.
Abstract Title: A phase III, randomized, controlled study to compare tivozanib with sorafenib in patients (pts) with advanced renal cell carcinoma (RCC)
Meeting Title: 2011 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 7 Suppl.
Meeting Dates: 2011 Feb 17-19
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-03-01
Language: English
ACCESSION: WOS:000208880700309
DOI: 10.1200/jco.2011.29.7_suppl.310
PROVIDER: wos
Notes: Meeting Abstract: 310 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer